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Abstract
Background: Q fever is a common cause of febrile illness and community-acquired pneumonia in resource-limited settings.
Coxiella burnetii, the causative pathogen, is transmitted among varied host species, but the epidemiology of the organism in
Africa is poorly understood. We conducted a systematic review of C. burnetii epidemiology in Africa from a ‘‘One Health’’
perspective to synthesize the published data and identify knowledge gaps.
Methods/Principal Findings: We searched nine databases to identify articles relevant to four key aspects of C. burnetii
epidemiology in human and animal populations in Africa: infection prevalence; disease incidence; transmission risk factors;
and infection control efforts. We identified 929 unique articles, 100 of which remained after full-text review. Of these, 41
articles describing 51 studies qualified for data extraction. Animal seroprevalence studies revealed infection by C. burnetii
(#13%) among cattle except for studies in Western and Middle Africa (18–55%). Small ruminant seroprevalence ranged
from 11–33%. Human seroprevalence was ,8% with the exception of studies among children and in Egypt (10–32%). Close
contact with camels and rural residence were associated with increased seropositivity among humans. C. burnetii infection
has been associated with livestock abortion. In human cohort studies, Q fever accounted for 2–9% of febrile illness
hospitalizations and 1–3% of infective endocarditis cases. We found no studies of disease incidence estimates or disease
control efforts.
Conclusions/Significance: C. burnetii infection is detected in humans and in a wide range of animal species across Africa,
but seroprevalence varies widely by species and location. Risk factors underlying this variability are poorly understood as is
the role of C. burnetii in livestock abortion. Q fever consistently accounts for a notable proportion of undifferentiated human
febrile illness and infective endocarditis in cohort studies, but incidence estimates are lacking. C. burnetii presents a real yet
underappreciated threat to human and animal health throughout Africa.
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Introduction
Coxiella burnetii, a zoonotic bacterial pathogen found worldwide
except in New Zealand, is transmitted to humans through direct
contact with milk, urine, feces, or semen from infected animals as
well as inhalation of aerosolized particles from animal placentas,
parturient fluids, aborted fetuses, and environmental dust [1].
While infection by C. burnetii in humans can be asymptomatic,
symptomatic infection, known as Q fever, can present as an acute
undifferentiated febrile illness with the possibility of focal
manifestations, such as hepatitis and pneumonia. Acute disease
can progress to chronic forms, such as endocarditis, in 0.5–2.0% of
cases [2,3], typically in individuals predisposed by valvular heart
disease or immunodeficiency [4]. Q fever is also one of the
infectious diseases that has been linked to chronic fatigue
syndrome [5]. Infection by C. burnetii has been demonstrated in
many animal species, but the principle reservoirs are thought to be
sheep, goats, and cattle. In these livestock species infection is often
asymptomatic but can cause abortion and reduce reproductive
efficiency [1,6].
Q fever has recently gained renewed attention after the largest-
ever recorded outbreak which involved over 3,500 human cases in
PLOS Neglected Tropical Diseases | www.plosntds.org 1 April 2014 | Volume 8 | Issue 4 | e2787
the Netherlands in 2007–2009 [7]. Recent studies in resource-
limited settings have demonstrated C. burnetii as a common cause
of febrile illness and community-acquired pneumonia [8–10].
Fever etiology research among hospitalized patients in northern
Tanzania found Q fever was a more common cause of severe
febrile illness than malaria [11,12]. As control efforts have led to
consistent decreases in malaria incidence throughout sub-Saharan
Africa [13–17] the diagnosis, treatment, and control of non-
malaria febrile illnesses, such as Q fever, are emerging as new
public health priorities [12]. In addition to being sources for
disease transmission to humans, C. burnetii infection in animals can
decrease livestock productivity which can have socioeconomic and
indirect health effects on humans, especially among livestock-
keeping populations in resource-limited settings [18].
In light of recent findings establishing Q fever as an important
cause of severe febrile illness in northern Tanzania [11,12] and
growing awareness of the potential economic impact of infection in
animals, we systematically reviewed the existing literature on the
epidemiology of C. burnetii infection among humans and animals in
Africa. This survey aimed to consolidate knowledge and identify
future research priorities for the following topics: the prevalence of
C. burnetii infection in human and animal populations, including
surveys of sera or shedding in body fluids; the incidence of disease
due to C. burnetii in human and animal populations; risk factors for
seropositivity or disease; and infection control efforts undertaken
in Africa.
Methods
Search
Nine databases were searched with the search string described
in Figure 1 including all countries in the 5 United Nations (UN)
sub-regions of Africa [19]. These search terms were adapted to the
particular language of each database, and for those databases that
did not allow the combination of Boolean operators, (q fever) OR
(Coxiella burnetii) was used. Two of the databases, CABI and
EBSCO Global Health, were searched with the intention to
include grey literature.
Selection and data extraction
Citations for all years and in all languages were compiled and
de-duplicated using EndNote (Thomson Reuters, New York,
USA). Abstracts were independently reviewed by two investigators
(SV and MPR) using combined language competency in English,
French, Spanish, and Portuguese or Google Translate (Google,
Mountain View, CA, USA) and included for full-text review upon
meeting predetermined criteria (Figure 2). Excluded abstracts
described studies conducted outside Africa, basic science or
immunology experiments, incorrect pathogens, reviews/editorials,
case reports or case series, Q fever among returning travelers,
periodical lay media content, diagnostic or therapeutic studies
without epidemiologic data, theoretical epidemiology, duplicate
data published elsewhere, textbooks/manuals, microbiologic
studies without epidemiologic data, or arthropod sampling. The
same criteria were applied during full-text review and to all grey
literature containing sufficient information for adjudication. Cases
of disagreement between the two investigators were resolved
through independent review by a third investigator (JEBH).
Prevalence of Coxiella burnetii infection
Prevalence studies that presented evidence of current or prior
infection with C. burnetii in humans and animals were included. We
considered the following serologic tests and minimum antibody
titer cut-offs for C. burnetii phase I and/or phase II antigen as
acceptable evidence of infection in humans and animals based on
expert consensus: complement fixation (CF) .1:10 for animals
[20] and $1:4 for humans, microscopic agglutination test (MAT)
$1:4 for humans and animals, indirect fluorescent antibody (IFA)
$1:25 for animals and $1:40 for humans, and ELISA validated
against one of the above methods [20–23]. Capillary agglutination
tests (CAT) were also accepted based on demonstrated correspon-
dence to CF titers [23,24]. The terms seropositive or seropositivity
are used throughout to describe serologic reactions that met these
titer cut-offs. For studies of pathogen shedding, confirmation of C.
burnetii by nucleic acid detection, culture, or rodent inoculation was
accepted. Studies of the prevalence of C. burnetii infection in
humans and animals were classified by extent of study population
characterization and sampling strategies, which were categorized
as random (e.g., proportional, simple cluster, or simple random) or
non-random. Prevalence studies that met these diagnostic criteria
and used randomized sampling strategies qualified for data
extraction. Prevalence studies with appropriate diagnostic criteria
that used non-random sampling were included but did not
undergo further data extraction.
Disease attributed to Coxiella burnetii
Studies reporting disease in animals due to C. burnetii were
included if the reported cases met the World Organization for
Figure 1. Databases and search terminology employed for
systematic review of Coxiella burnetii epidemiology in Africa, all
years.
doi:10.1371/journal.pntd.0002787.g001
Author Summary
Coxiella burnetii is a bacterium that can cause acute and
chronic fever illness and pneumonia in humans. It is also a
known cause of abortion in livestock species, and is
principally transmitted to humans through contact with
infected animal birth products. With growing awareness of
the over-diagnosis and misclassification of malaria as the
cause of fever illnesses in the tropics, including Africa,
there is increased interest in the role of non-malarial
causes of fever, such as C. burnetii. We performed a
systematic review of the published literature on the
epidemiology of C. burnetii in Africa to consolidate
knowledge and identify knowledge gaps regarding the
extent of this infection in humans and animals and the risk
factors for infection transmission. Few studies on preva-
lence of infection in humans and animals used random
sampling strategies, and among these only two studied
linked human and animal populations. C. burnetii appears
to be a common cause of severe fever illness in humans,
but population-level incidence estimates are lacking. The
differential risks for C. burnetii infection and potential
control strategies within the various animal husbandry
systems in Africa remain largely unexplored. We conclude
that C. burnetii is an underappreciated threat to human
and animal health throughout Africa.
Coxiella burnetii in Africa
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Animal Health (OIE) case definition for Q fever: abortion and/or
stillbirth plus confirmed presence of the bacterial agent, accom-
plished by 1) isolation in culture; or 2) polymerase chain reaction
(PCR), in situ hybridization, or immunohistochemistry of birth
products or of associated vaginal discharge [20]. Evidence of C.
burnetii on placental smears with stains deemed appropriate by
OIE (Stamp, Ziehl-Neelsen, Gimenez, Giemsa or modified
Koster) were considered presumptive for disease and included
[20]. We also included seroprevalence studies of animals with a
history of abortion, as these data, although not of confirmed cases,
could yield information about potential associations between C.
burnetii exposure and prevalence of animal abortion.
For studies of disease in humans, acute Q fever was defined
according to the US Centers for Disease Control and Prevention
(CDC) case definition: a compatible fever syndrome plus four-fold
rise in antibody titers to Phase II antigen or detection in clinical
specimens by PCR, immunohistochemistry (IHC), or culture [25].
Phase II antigen IFA antibody titer levels for IgG$1:200 and
Figure 2. Selection of eligible articles concerning Coxiella burnetii epidemiology in Africa.
doi:10.1371/journal.pntd.0002787.g002
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IgM$1:50 were included as cases based on the high positive
predictive value of such results [26]. Studies reporting chronic
disease in humans due to Q fever were included if the reported
cases met the CDC case definition for confirmed chronic Q fever:
culture-negative endocarditis or infected vascular aneurysm,
chronic hepatitis, osteomyelitis, osteoarthritis, or pneumonitis with
no other etiology plus IFA IgG antibody to C. burnetii phase I
antigen $1:800 or detection in clinical specimens by PCR, IHC,
or cell-culture [25].
Risk factors for Coxiella burnetii infection or disease
Risk factor studies were evaluated using the same criteria for
sampling design and case definitions that were applied to surveys
of prevalence or disease, respectively. Risk factor analyses in
prevalence studies were excluded if the prevalence study used a
non-random sampling strategy.
Coxiella burnetii control efforts
Studies describing control efforts must have presented original
data demonstrating the outcome of an intervention to decrease
infection or disease incidence in human and/or animal popula-
tions.
Data extraction and analysis
For all qualifying studies, extracted data included study country,
city or region, species, population census data when given, sample
size, year of study, and diagnostic test as well as the number of
seropositive or disease cases, risk factors, or control effort data
where applicable. In the case of incomplete data or unclear
methods, authors were contacted for further clarification when
possible. Descriptive analyses of the extracted data were conduct-
ed. No quantitative meta-analysis was undertaken.
Results
A total of 1,662 citations were identified by the search
conducted on December 3, 2012. After duplicates were removed,
929 articles remained (Figure 2). Four of the six authors we
contacted for further clarification responded to our inquiries.
Ultimately, 100 articles describing 120 studies remained after full-
text review. Forty-one articles describing 51 studies qualified for
data extraction. The other 59 articles described 69 prevalence
studies that did not qualify for data extraction due to non-random
sampling methods (Table S1). Studies qualifying for data
extraction were grouped into the following categories: 8 human
and 13 animal seroprevalence; 3 animal milk shedding; 10 human
disease; 7 animal abortion; and 7 human and 3 animal risk factor
studies. These 51 studies spanned the years 1965–2012 and were
conducted in 15 countries, mostly concentrated in the UN sub-
regions of Northern, Western, and Middle Africa (Table 1 &
Figure 3).
Prevalence of Coxiella burnetii infection
Two surveys employed a systematic sampling strategy to assess
seroprevalence among linked human and animal populations. The
first, from three governorates surrounding Cairo, Egypt, reported
C. burnetii seropositivity in 13% of cattle, 23% of goats, 33% of
sheep, 0% of buffalo, and 16% of humans in close contact with
these animals [27]. The second survey, undertaken in Chad, found
80% of camels, 4% of cattle, 13% of goats, 11% of sheep, and 1%
of humans in close contact were seropositive [28]. All other
seroprevalence studies sampled only humans or only animal
species (Table 1).
Surveys of cattle demonstrated seroprevalence ranging from 4%
in Dakar, Senegal [29], to 55% around the city of Zaria, Nigeria
[30,31]. Other studies reporting cattle seroprevalence within this
range were conducted in coastal Ghana (18%) [32], Cameroon’s
Adamawa Region (32%) [33], southern Chad (7%) [34], and
South Africa’s Transvaal Province (8%) [35]. Goat seropositivity
ranged from 13% in Chad [28] to 23% in Egypt [27] and 24% in
8 Sudanese states [36]. Surveys of sheep revealed seroprevalences
that ranged from 11% in Chad [28] to 33% in Egypt [27]. In
Upper Egypt, 23% of dog sera samples indicated prior C. burnetii
infection [37].
In studies of pathogen shedding in bovine milk, C. burnetii
nucleic acid was detected in 22% of raw milk samples in Upper
Egypt [38]. In Zaria, Nigeria, C. burnetii shedding among
individual cows was reported in 63% of milk samples from
extensively managed cattle and 43% of samples from semi-
intensively managed cattle [30], whereas the prevalence was 26%
and 22%, respectively, at the same location one year later [31]. No
studies of shedding in fluids other than milk in asymptomatic
humans or animals were found by our search, and no human milk
shedding studies qualified for data extraction.
Seroprevalence in humans ranged from 1% in Chad [28] to
32% in a Nile Delta village in Egypt [39]. In Niamey, Niger, 10%
of children ages 1 month-5 years were seropositive [40], and in
Ghana’s rural Ashanti Region, 17% of two-year-olds were
seropositive [41]. Other surveys reported human seroprevalence
at 5% in rural western Coˆte d’Ivoire [42], 8% among nomads
sampled in rural northern Burkina Faso [43], and 5% of pregnant
women attending an antenatal clinic in Dar es Salaam, Tanzania
[44].
Disease attributed to Coxiella burnetii
Of disease studies in humans or animals, none estimated disease
incidence, and two studies [45,46] of livestock abortions met OIE
definitions for either presumptive or confirmed cases. The
remaining 5 animal abortion studies were serological investigations
in individuals with history of abortions [34,47–50].
Of two surveys of cattle with abortions in northern Cameroon,
one did not detect serological evidence of C. burnetii infection in
any cattle [50], while 3% in the other study were seropositive,
compared to 7% among a non-random selection of cattle without
abortions [34]. In South Africa, C. burnetii was found by smear
microscopy in aborted calf fetuses at all of six cattle farms sampled
[46].
In the Maradi Region of Niger, 32% of goats with previous
abortions were seropositive, compared to 29% of non-randomly
selected goats without a history of abortion [47]. Sheep with a
history of abortion in Rabat, Morocco, were more likely than
those with normal births to be seropositive for C. burnetii, 33%
versus 15% (p,0.01) [48]. In a survey conducted in five Tunisian
governorates, 7% of sheep without past abortions were seropos-
itive for C. burnetii compared to 12% of small ruminants with
previous abortions [49]. Another Tunisian study found that 19%
of small ruminants with a history of abortion had C. burnetii
detected by PCR analysis of birth products or vaginal secretions
[45], and in South Africa, the pathogen was found by smear
microscopy in aborted lamb fetuses from all of six sheep farms
sampled [46].
Human cohorts comprising individuals with infective endocar-
ditis in Sousse and Sfax, Tunisia, as well as Algiers, Algeria, have
demonstrated C. burnetii as the causative pathogen in 1–3% of cases
[51–53]. Two studies of febrile patients in Sousse, Tunisia,
serologically identified acute Q fever in 2% and 9% of hospital
admissions [54,55]. Q fever was responsible for 5% of patients
Coxiella burnetii in Africa
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Table 1. Studies of Coxiella burnetii infection prevalence and disease prevalence in humans and animals in Africa that qualified for
data extraction.
Sub-Region Study Type Country Species (n) Study Year(s) Sample
Number
Positive (%) Ref
Northern Prevalence Egypt Dogs (150) 1998–1999 serum 34 (23%) [37]
Egypt Buffalo (45) 2012* serum 0 (0%) [27]
Cattle (54) 7 (13%)
Goats (30) 7 (23%)
Sheep (55) 18 (33%)
Humans (92) 15 (16%)
Egypt Cattle (100) 2009* milk 22 (22%) [38]
Egypt Humans (883) 1991 serum 285 (32%) [39]
Sudan Goats (460) 2010–2011 serum 109 (24%) [36]
Disease Morocco Sheep prior abortion (115)
and controls (156)
1986–1987 serum 38 (33%) and
23 (15%)
[48]
Tunisia Goats & Sheep prior
abortion (118) and Sheep
controls (517)
1997 serum 22 (12%) and
35 (7%)
[49]
Tunisia Goats & Sheep abortion (72) 2009* birth products/
vaginal fluids
14 (19%){ [45]
Tunisia Human febrile illness (300) 1993–1994 serum 5 (2%) [54]
Tunisia Human febrile illness (47) 2004 serum 4 (9%) [55]
Tunisia Human endocarditis (98) 1991–2000 blood 1 (1%) [51]
Tunisia Human endocarditis (33) 2008 serum 1 (3%) [52]
Algeria Human endocarditis (61) 2000–2003 serum 2 (3%) [53]
Western Prevalence Nigeria Cattle (306) Cattle (84) 1983–1984 serum milk 169 (55%) 44
(52%)
[30]
Nigeria Cattle (88) Cattle (169) 1983–1984 serum milk 48 (55%) 41
(24%)
[31]
Senegal Cattle (196) 2007–2008 serum 7 (4%) [29]
Ghana Cattle (166) 2012* serum 30 (18%) [32]
Cote d’Ivoire Humans (949) 1965 serum 44 (5%) [42]
Burkina Faso Humans (1309) 1975* serum 100 (8%) [43]
Niger Humans, children (177) 1994 serum 17 (10%) [40]
Ghana Humans, children (219) 2008* serum 37 (17%) [41]
Disease Niger Goats prior abortion (75)
and controls (47)
1971–1972 serum 24 (32%)
and 12 (29%)
[47]
Burkina Faso Human febrile illness (183) 1995 serum 9 (5%) [56]
Middle Prevalence Chad Cattle (193) 1985* serum 13 (7%) [34]
Chad Camels (142) 1999–2000 serum 114 (80%) [28]
Cattle (195) serum 8 (4%)
Goats (134) serum 18 (13%)
Sheep (142) serum 16 (11%)
Humans (368) serum 4 (1%)
Cameroon Cattle (1377) 2000 serum 431 (32%) [33]
Disease Cameroon Cattle prior abortion (116) 1968* serum 0 (0%) [50]
Cameroon Cattle prior abortion (490)
and controls (193)
1985* serum 14 (3%) and
13 (7%)
[34]
Cameroon Human pneumonia (110) 1991–1992 serum 6 (6%) [57]
Cameroon Human pneumonia (65) 1991–1993 serum 6 (9%) [58]
Southern Prevalence South Africa Cattle (8900) 1985–1986 serum 692 (8%) [35]
Disease South Africa Cattle (6 farms) and sheep
(6 farms) abortions
1972–1976 fetal tissue 12 (100%)
farms+
[46]
South Africa Human pneumonia (92) 1987–1988 serum 0 (0%) [59]
Coxiella burnetii in Africa
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with acute febrile illness hospitalized in Bobo-Dioulasso, Burkina
Faso [56] as well as 3% of pediatric and 8% of adult admissions for
severe febrile illness at two referral hospitals in the Kilimanjaro
Region of northern Tanzania [11]. In two studies of patients
admitted for community-acquired pneumonia in Yaounde´ and
Douala, Cameroon, 6% and 9% of persons aged .15 years had
serologically-confirmed acute Q fever [57,58]. In these studies, Q
fever was the third most common etiologic agent of pneumonia,
after Streptococcus pneumoniae and Mycoplasma pneumoniae. At a major
hospital in Cape Town, South Africa, C. burnetii was not found to
be the cause of any pneumonia cases in a 92-patient cohort [59].
Risk factors for Coxiella burnetii infection or disease
Among Nigerian cattle near Zaria, no difference in seroposi-
tivity was detected for cattle managed semi-intensively versus
extensively [30,31]. In Cameroon, positive associations were found
between seropositivity and cattle aged .2 years, female animals,
those seen grazing with buffalo, and those for which the owner’s
ethnic group was recorded as Mbororo or ‘other’ when compared
to Fulbe [33,60].
In the Egypt study linking human and animal populations, rural
human residents were more likely to test seropositive than those in
urban areas [27]. In the linked study from Chad, human Q fever
serostatus did not correlate with the proportion of seropositive
animals within respective nomadic camps, and camel breeders
were at higher risk for Q fever seropositivity than cattle breeders
[28]. In Ghana, children of illiterate mothers had a two-fold higher
risk of seropositivity compared to those of literate mothers [41].
There was no association detected between C. burnetii seropositivity
and HIV serostatus in pregnant Tanzanian women [44]. In the
hospitalized patient cohort in northern Tanzania, there was no
difference in prevalence of acute Q fever infection in HIV-infected
compared to HIV-uninfected individuals [11], and all cases of
community-acquired pneumonia in the surveys of hospitalized
patients in Cameroon were in HIV uninfected individuals [57,58].
No studies of risk factors for animal disease remained after quality
assessment.
Coxiella burnetii control efforts
No disease control studies were found by our search.
Discussion
The serological data reviewed in this study reveal evidence of
widespread C. burnetii infection in multiple species and multiple
sites throughout Africa. However, despite evidence of the
pervasiveness of this pathogen, we found only 17 studies that
used appropriate case definitions to quantify disease due to C.
burnetii in humans and animals. Risk factors for exposure in
humans and animals have been identified in some settings, but
apart from assessing for associations between HIV and Q fever, we
found no other evaluation of the epidemiologic risk factors for
acute disease in animals or humans. No descriptions of disease
control programs appear in published literature. C. burnetii was first
reported in Africa in 1947 [61], but since then, the quantity and
quality of epidemiologic research for this pathogen has been
limited. We identified no disease incidence estimates, and the
majority of research undertaken has limited validity due to non-
random sampling procedures. Further, only two investigations
using random sampling procedures studied linked human and
animal livestock populations.
The majority of animal prevalence studies surveyed cattle,
sheep, and goats. Studies of herds in Northern Africa, the Sahel
and South Africa’s Transvaal Province suggest C. burnetii infection
in multiple ruminant species. Seroprevalence of C. burnetii#13% is
frequently demonstrated in cattle [27–29,34,35] and generally
higher seroprevalence (11–33%) is often observed among small
ruminants [27,28,36,48]. However, this pattern was not observed
in all studies [30–33]. Our review revealed wide variation in
seroprevalence even in areas of close proximity such as Lake
Chad, where seroprevalence in cattle ranged from 4% to 31%
[28,33]. This is consistent with findings of high regional variability
within Europe [62] and highlights the importance of understand-
ing risk factors which may operate at a local scale and may be
subtle. For example, risk factor analysis revealed that cattle
seropositivity differed by owner’s ethnic group (Mbororo vs. Fulbe)
in Cameroon, despite these groups’ similar nomadic pastoralism
[60]. Herds raised by unspecified ‘other ethnic groups’ had an
even greater risk of infection, highlighting the need to further
explore how different animal husbandry practices might modify
infection risk for humans and animals. Further, the high
seroprevalence observed in camels and the greater infection risk
among Arab camel breeders compared to cattle breeders warrants
further investigation of C. burnetii infection in camels and the
potential risk factors related to camel husbandry practices [28].
Human seroprevalence was ,8% [28,42–44] with the excep-
tion of surveys in children and in the Nile Delta of Egypt [27,39–
41]. A recent survey in The Gambia found C. burnetii seroprev-
alence was highest in young children, although the reasons for this
are still unclear [63]. In the only risk factor analysis among
children found by our search, Ghanaian children with illiterate
mothers were more likely to be seropositive than children with
literate mothers, but no difference was attributable to other
socioeconomic factors tested [41]. The study of Egyptians in close
contact with animals reported a high overall seroprevalence (16%)
with greater seropositivity among rural (22%) vs. urban (4%)
residents [27]. In contrast, the only other linked human-animal
survey studied nomads in Chad, and found a relatively low human
seropositivity (1%), despite the high-risk behaviors of handling
aborted animal materials and consuming raw cow’s milk [28],
Table 1. Cont.
Sub-Region Study Type Country Species (n) Study Year(s) Sample
Number
Positive (%) Ref
Eastern Prevalence Tanzania Humans, pregnant
females (150)
1993 serum 7 (5%) [44]
Disease Tanzania Human febrile illness (483) 2007–2008 serum 24 (5%) [11]
*Year(s) of sample collection for study unavailable; year of publication included instead.
+C. burnetii detection by impression smear microscopy. Positive results were not provided at an individual animal level, only at the level of investigated farms.
{C. burnetii detection by polymerase chain reaction.
doi:10.1371/journal.pntd.0002787.t001
Coxiella burnetii in Africa
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which was shown to contain C. burnetii in 15–63% of samples from
other African settings [30,31,38].
Only two studies [45,46] used direct detection of C. burnetii in
animal acute disease cases. The other studies investigating the
potential role of C. burnetii as a cause of livestock abortions in
Africa measured the seroprevalence in individuals with history of
abortion as compared to individuals without history of abortion.
Two cohort studies found no difference between C. burnetii
seroprevalence in cattle with previous abortions compared to
those without history of abortion [34,50]. Similar studies in sheep
and goats, by contrast, generally showed a higher C. burnetii
seroprevalence in individuals with history of abortion compared to
those without history of abortion [45,47–49]. This serologic
approach, however, has limited value for inferring causation in
livestock abortion cases, which is compounded by non-random
selection of control livestock without abortions in all but one study
[30].
Q fever accounted for 2–9% of humans hospitalized for
febrile illness in 3 different African sub-regions [11,54–56].
Although Q fever was the third most common detected cause of
Figure 3. Locations of Coxiella burnetii infection prevalence and disease studies in African humans and animals which qualified for
data extraction.
doi:10.1371/journal.pntd.0002787.g003
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community-acquired pneumonia at two of Cameroon’s largest
hospitals [57,58], no cases of community-acquired pneumonia
were attributed to C. burnetii after a year-long survey at a Cape
Town hospital [59]. Interestingly, all of the Cameroonian patients
were HIV-uninfected, and in the Tanzania severe febrile illness
cohort there was no association between HIV serostatus and acute
Q fever [11,44]. The proportion of infective endocarditis cases in
Africa attributed to C. burnetii was slightly lower than proportions
found in European settings [64]. However, all endocarditis studies
found by our review were conducted in Northern Africa [51–53],
highlighting a key knowledge gap on the role of Q fever in
endocarditis elsewhere on the continent.
We identified few studies that elucidated the epidemiologic risk
factors for C. burnetii infection in humans and animals in Africa.
This knowledge gap highlights the need for future studies that
randomly sample linked human-animal populations in order to
estimate seroprevalence and determine the dynamics of pathogen
transmission. Such research requires large, representative samples
as well as detailed surveys of herds and households from multiple
locations, agricultural systems, and ethnic groups.
C. burnetii is clearly an important cause of human and animal
disease in Africa, although illness and death have not been
estimated at the population level. In animals, C. burnetii has been
implicated as an etiologic agent of abortion in livestock from the
most northern to the most southern reaches of the continent, but
studies should include confirmatory microbiological and histo-
logical testing of abortion materials, descriptions of other disease
sequelae, randomly sampled non-aborting controls, and tandem
serological and bacterial shedding surveys to determine the rate
of asymptomatic shedding. Estimates of economic losses due to
decreases in milk production, fecundity, or birth weight are also
needed. For humans, limited data suggest that Q fever
frequently causes severe febrile illness in cohorts throughout
Africa, yet no studies quantifying disease incidence, disability, or
deaths at the population level exist. Further, aside from infective
endocarditis studies, proportions and clinical features of
conversion to chronic Q fever in African populations are absent.
Limitations
Superseded geographic or biological terminology may have
caused us to inadvertently miss pertinent research. The already
remote chances of communicating with authors of older manu-
scripts were complicated by the absence of electronic contact
information. We excluded arthropod vector studies, but surveys of
invertebrates and non-domestic animals may contribute to
knowledge about C. burnetii transmission. Comparisons between
studies and sub-regions were restricted by changes in diagnostic
methods over time, frequently small sample sizes, and the low total
number of studies. The low number of studies for each research
question and the heterogeneity of these studies precluded a more
extensive quantitative analysis of the epidemiology of C. burnetii in
Africa.
Conclusions
To our knowledge, this is the first systematic review of the
epidemiology of C. burnetii in Africa from a ‘One Health’
perspective. Taken together, these findings suggest: 1) exposure
to C. burnetii is a common finding in many animal host species
across Africa, but seroprevalence varies widely by species and
location, and the risk factors underlying this variability are
largely unknown; 2) C. burnetii has been implicated as a cause of
livestock abortion and could be responsible for substantial
economic burdens, but more rigorous studies are required to
determine this and other sequelae of disease in animals; 3) risk
factors for human exposure to Q fever are poorly understood,
but a more detailed understanding of how human exposure in
different communities is linked with animal infection patterns
and animal husbandry practices is clearly needed; and 4) Q
fever accounts for a notable proportion of undifferentiated
human febrile illness and infective endocarditis but studies
describing other acute or chronic disease manifestations are
scarce. The picture is complex, but the existing literature
suggests that C. burnetii is found across diverse settings in Africa
and presents a real yet underappreciated threat to human and
animal health throughout Africa.
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